Pyridazinylpiperazines and their use as histamine H3 receptor ligands

Details for Australian Patent Application No. 2004259263 (hide)

International Classifications

Event Publications

2 February 2006 PCT application entered the National Phase

PCT publication WO2005/009976 Priority application(s): WO2005/009976

31 July 2008 Assignment before Grant

Novo Nordisk A/S The application has been assigned to TransTech Pharma, Inc.

19 February 2009 Assignment before Grant

TransTech Pharma, Inc. The application has been assigned to High Point Pharmaceuticals, LLC

16 December 2010 Application Accepted

Published as AU-B-2004259263

14 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.